Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Sales

BioScience Health Innovations (BHIC) Debt Ratio (2019 - 2022)

BioScience Health Innovations (BHIC) has disclosed Debt Ratio for 4 consecutive years, with 0.12 as the latest value for Q2 2022.

  • Quarterly Debt Ratio fell 99.73% to 0.12 in Q2 2022 from the year-ago period, while the trailing twelve-month figure was 0.12 through May 2022, down 99.73% year-over-year, with the annual reading at 2.76 for FY2021, 3645.65% up from the prior year.
  • Debt Ratio for Q2 2022 was 0.12 at BioScience Health Innovations, up from 0.04 in the prior quarter.
  • The five-year high for Debt Ratio was 44.12 in Q2 2021, with the low at 0.04 in Q1 2022.
  • Average Debt Ratio over 4 years is 5.06, with a median of 0.7 recorded in 2020.
  • The sharpest move saw Debt Ratio surged 15667.37% in 2021, then tumbled 99.73% in 2022.
  • Over 4 years, Debt Ratio stood at 0.76 in 2019, then decreased by 7.82% to 0.7 in 2020, then crashed by 82.83% to 0.12 in 2021, then decreased by 2.02% to 0.12 in 2022.
  • According to Business Quant data, Debt Ratio over the past three periods came in at 0.12, 0.04, and 0.12 for Q2 2022, Q1 2022, and Q4 2021 respectively.